DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Catalyst Pharmaceutical Partners, Inc. (CPRX)
« Back to company indexCPRX Chatter Timeline
Stock Ticker for CPRX
Most Active Tweeters for CPRX
No tweets foundRecent Tweets for CPRX
 |
@chickpea598 $ONCS $CPRX Catalyst Pharma is another Orphan Drug Company with huge potential to keep an eye on as they move close… https://t.co/P94MuUGQtQ August 21st 2018, 5:08pm |
 |
@registrarjourn Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/czCEbwQgge August 20th 2018, 2:08pm |
 |
@EnterpriseLeade Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/CQSy8IIM7m August 20th 2018, 2:08pm |
 |
@Allstocknews $CPRX Catalyst Pharmaceuticals Appoints Dr. Stanley Iyadurai as Vice President of Clinical Development From our Stock News Alerts App August 20th 2018, 8:08am |
 |
@ConsumerFeed Catalyst Pharmaceuticals Inc $CPRX Receives Consensus Recommendation of “Buy” from Brokerages https://t.co/M2mAdCCAfa August 19th 2018, 9:08pm |
 |
@alexrome20 Binance reopen limited user registration Register link and BONUS ? https://t.co/FvxrxuwdVQ ? 08/19 12:08 $CPRX… https://t.co/8QcaSV1VU8 August 19th 2018, 12:08pm |
 |
@Ironcookies $cprx expanding https://t.co/CK5VtNvP00 August 19th 2018, 10:08am |
|
@registrarjourn Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub to “Strong Sell” https://t.co/YaFIFQLQED August 18th 2018, 3:08pm |
|
@EnterpriseLeade Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub to “Strong Sell” https://t.co/i4dOF4U9EV August 18th 2018, 3:08pm |
 |
@Stock_News_Now $CPRX: New SEC Filing for CPRX: Form 8-K (No. 0001193125-18-251807): https://t.co/uNy8YKrvcY August 17th 2018, 5:08pm |
 |
@usindexlive As Catalyst Pharmaceuticals $CPRX Shares Rose, Shareholder Great Point Partners Trimmed Its Holding by $2.68 Billio… https://t.co/EIYWNV5aPz August 17th 2018, 4:08pm |
 |
@TheMarketsDaily Catalyst Pharmaceuticals Inc $CPRX Receives $5.71 Consensus Price Target from Analysts https://t.co/xPfyOrd4hp August 17th 2018, 1:08pm |
 |
@dakotafinancial Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/SMioq6L4ur August 17th 2018, 9:08am |
 |
@MareaInformativ Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/LVOvYkv5e9 August 17th 2018, 9:08am |
|
@TheMarketsDaily Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/sukMgOpxR2 August 17th 2018, 9:08am |
|
@MareaInformativ Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/7RbZRxhpKx August 17th 2018, 6:08am |
 |
@TickerReport Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/vSlf7IIghz August 17th 2018, 2:08am |
 |
@dailypoliticaln Catalyst Pharmaceuticals Inc to Post Q3 2018 Earnings of -$0.11 Per Share, SunTrust Banks Forecasts $CPRX https://t.co/U5d8tz7SLK August 17th 2018, 2:08am |
 |
@ThisLincolnian Catalyst Pharmaceuticals $CPRX Upgraded at Zacks Investment Research https://t.co/SNIdYubZo5 August 16th 2018, 11:08am |
 |
@WatchlistN Weekly Research Analysts’ Ratings Updates for Catalyst Pharmaceuticals $CPRX https://t.co/T9Ilzllefc August 16th 2018, 11:08am |
 |
@AmericanBanking Weekly Research Analysts’ Ratings Updates for Catalyst Pharmaceuticals $CPRX https://t.co/wYnLt0B887 #stocks August 16th 2018, 11:08am |
|
@Ironcookies RT @bbnsnews: Zacks Investment Research Upgrades Catalyst Pharmaceuticals $CPRX to Buy https://t.co/HFQbVJMXoO August 16th 2018, 9:08am |
 |
@bbnsnews Zacks Investment Research Upgrades Catalyst Pharmaceuticals $CPRX to Buy https://t.co/HFQbVJMXoO August 16th 2018, 7:08am |
 |
@TranscriptDaily SunTrust Banks Weighs in on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/G2lkNj7cQy August 16th 2018, 1:08am |
|
@MareaInformativ Catalyst Pharmaceuticals $CPRX Posts Earnings Results, Beats Expectations By $0.02 EPS https://t.co/3R50NWLVbx August 15th 2018, 3:08pm |
|
@MareaInformativ Oppenheimer Comments on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/5XhBQuRB7J August 15th 2018, 9:08am |
|
@usindexlive Great Point Partners Trimmed Its Stake in Catalyst Pharmaceuticals $CPRX as Market Valuation Rose; Central Securiti… https://t.co/rAJgovJDIR August 15th 2018, 8:08am |
|
@AmericanBanking Catalyst Pharmaceuticals Inc Expected to Post Q3 2018 Earnings of -$0.11 Per Share $CPRX https://t.co/fl0gugN51S #stocks August 15th 2018, 6:08am |
|
@ConsumerFeed Catalyst Pharmaceuticals $CPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/cPneNINZQn August 15th 2018, 5:08am |
|
@ThisLincolnian Oppenheimer Comments on Catalyst Pharmaceuticals Inc’s Q3 2018 Earnings $CPRX https://t.co/i0zZX2r84u August 15th 2018, 4:08am |
|
@EnterpriseLeade BidaskClub Downgrades Catalyst Pharmaceuticals $CPRX to Sell https://t.co/Ox3ApI6tyV August 14th 2018, 6:08pm |
|
@TranscriptDaily Catalyst Pharmaceuticals $CPRX Lifted to Buy at Zacks Investment Research https://t.co/ebc2nzmI5u August 14th 2018, 12:08pm |
|
@bbnsnews Catalyst Pharmaceuticals Inc $CPRX to Post Q3 2018 Earnings of -$0.08 Per Share, Oppenheimer Forecasts https://t.co/lAh07A1nBN August 14th 2018, 6:08am |
 |
@dispatchtribune Catalyst Pharmaceuticals Inc $CPRX Receives Consensus Rating of “Buy” from Analysts https://t.co/hREob0MyGV August 14th 2018, 4:08am |
|
@AmericanBanking Catalyst Pharmaceuticals Inc $CPRX Given Average Rating of “Buy” by Brokerages https://t.co/agxJEMpHzS #stocks August 14th 2018, 4:08am |
|
@Ironcookies RT @bbnsnews: Catalyst Pharmaceuticals $CPRX Given a $6.00 Price Target at Oppenheimer https://t.co/wgIffDroQk August 13th 2018, 11:08pm |
|
@MareaInformativ Catalyst Pharmaceuticals $CPRX Stock Rating Lowered by BidaskClub https://t.co/66KrghKXWd August 13th 2018, 7:08pm |
|
@registrarjourn Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/czCEbwQgge August 13th 2018, 2:08pm |
|
@EnterpriseLeade Catalyst Pharmaceuticals $CPRX Upgraded by Zacks Investment Research to Buy https://t.co/CQSy8IIM7m August 13th 2018, 2:08pm |
|
@ThisLincolnian Catalyst Pharmaceuticals $CPRX Stock Rating Reaffirmed by HC Wainwright https://t.co/SpvFdD9VWx August 13th 2018, 2:08pm |
 |
@WeekHerald Catalyst Pharmaceuticals $CPRX Rating Reiterated by HC Wainwright https://t.co/8JGk1Wa6Fu August 13th 2018, 2:08pm |
|
@bbnsnews Catalyst Pharmaceuticals $CPRX Given a $6.00 Price Target at Oppenheimer https://t.co/wgIffDroQk August 13th 2018, 12:08pm |
|
@Ironcookies RT @MareaInformativ: Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/gmo2RiG4kc August 13th 2018, 10:08am |
|
@AmericanBanking Q3 2018 EPS Estimates for Catalyst Pharmaceuticals Inc $CPRX Lifted by Analyst https://t.co/QfKdkKJmhK #stocks August 13th 2018, 3:08am |
 |
@ZolmaxNews Q3 2018 EPS Estimates for Catalyst Pharmaceuticals Inc $CPRX Lifted by Analyst https://t.co/36zSrwXDXe August 13th 2018, 3:08am |
|
@MareaInformativ Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/gmo2RiG4kc August 12th 2018, 1:08pm |
|
@WatchlistN Catalyst Pharmaceuticals $CPRX Earns Buy Rating from HC Wainwright https://t.co/1HYjBwephJ August 12th 2018, 1:08pm |
|
@ConsumerFeed Oppenheimer Reiterates $6.00 Price Target for Catalyst Pharmaceuticals $CPRX https://t.co/7IUqb0LAi1 August 12th 2018, 1:08pm |
|
@WatchlistN Catalyst Pharmaceuticals $CPRX Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS https://t.co/DVSNvrDQxH August 12th 2018, 11:08am |
|
@ConsumerFeed Catalyst Pharmaceuticals $CPRX Downgraded by BidaskClub https://t.co/1zSfGt7Gmu August 12th 2018, 11:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.